Please wait
0001818794EX-FILING FEESfalse 0001818794 2025-03-27 2025-03-27 0001818794 1 2025-03-27 2025-03-27 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form
S-8
(Form Type)
Dyne Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
               
Security Type
  
Security
Class
Title
  
Fee
Calculation
Rule
  
Amount
Registered(1)
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
  
Amount of
Registration
Fee
               
Equity   Common stock, par value $0.0001 per share   Other(2)    1,000,000(3)   $11.89 (2)    $11,890,000.00   0.0001531   $1,820.36
         
Total Offering Amounts
     $11,890,000.00     $1,820.36
         
Total Fee Offsets
         —
         
Net Fee Due
               $1,820.36
 
(1)
In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low sales price of the registrant’s common stock on the Nasdaq Global Select Market on March 25, 2025.
(3)
Consists of 1,000,000 additional shares issuable under the 2024 Inducement Stock Incentive Plan, as amended.